A Division of JPPL

Quality Healthcare Solutions

Mecon Life Science delivers innovative pharmaceutical products with uncompromising quality standards, serving healthcare professionals and patients worldwide.

30+
Years of Excellence
800+
Products
75+
Countries
Healthcare Professional

FDA Approved

ISO Certified

WHO Listed

GMP Certified

EU Approved

Mecon Facility

30+

Years of Excellence

Our Company

Leading the Way in Pharmaceutical Innovation

Mecon Life Science, a proud division of JPPL, has been at the forefront of pharmaceutical manufacturing and distribution for over three decades. We are committed to improving global health through innovative medications and unwavering dedication to quality.

ISO Certified

International quality standards compliance

Global Reach

Serving 75+ countries worldwide

Expert Team

1000+ pharmaceutical professionals

FDA Approved

Meeting international standards

Why Choose Us

Excellence in Pharmaceutical Care

Committed to delivering the highest quality medications with patient safety and efficacy at the forefront of everything we do.

Quality Assurance

Every product undergoes rigorous testing and quality control processes to ensure they meet international pharmaceutical standards and regulatory requirements.

Research & Innovation

State-of-the-art research facilities and dedicated scientists working on breakthrough treatments for complex medical conditions and diseases.

Patient-Centric Approach

Designed with patient well-being in mind, focusing on safety, efficacy, and accessibility to ensure better health outcomes for all.

Global Presence

Trusted pharmaceutical partner with distribution networks spanning across 75+ countries, ensuring accessibility to quality healthcare worldwide.

Expert Team

Experienced healthcare professionals, pharmacists, and researchers dedicated to advancing pharmaceutical science and patient care.

Sustainability

Committed to environmentally responsible manufacturing practices and sustainable pharmaceutical development for a healthier planet.

Our Portfolio

Comprehensive Product

Discover our innovative pharmaceutical solutions designed to improve patient outcomes across multiple therapeutic areas.

NUMFLOZIN-1000
Gastro/Digestive

NUMFLOZIN-1000

Sodium Bicarbonate 1000 mg for effective relief from acidity and indigestion.

Form: Tablets
Solrab-20 Popular
Gastro/Digestive

Solrab-20

Rabeprazole 20 mg - Proton pump inhibitor for acid-related disorders.

Form: Gastro Resistant Tablets
Amarpan-40
Gastro/Digestive

Amarpan-40

Pantoprazole 40 mg for treatment of GERD and gastric ulcers.

Form: Gastro Resistant Tablets
Panmac-40
Gastro/Digestive

Panmac-40

Pantoprazole 40 mg - Advanced gastric acid suppression therapy.

Form: Gastro Resistant Tablets
Esomtus-40
Gastro/Digestive

Esomtus-40

Esomeprazole 40 mg - Premium PPI for acid reflux management.

Form: Gastro Resistant Tablets
LEVOTAS-M New
Allergy/Respiratory

LEVOTAS-M

Levocetirizine + Montelukast for allergic rhinitis and asthma.

Form: Tablets
NUMFLOZIN-1000
Gastro/Digestive

NUMFLOZIN-1000

Sodium Bicarbonate 1000 mg for effective relief from acidity and indigestion.

Form: Tablets
Solrab-20 Popular
Gastro/Digestive

Solrab-20

Rabeprazole 20 mg - Proton pump inhibitor for acid-related disorders.

Form: Gastro Resistant Tablets
Amarpan-40
Gastro/Digestive

Amarpan-40

Pantoprazole 40 mg for treatment of GERD and gastric ulcers.

Form: Gastro Resistant Tablets
AMARACE-SP
Pain & Inflammation

AMARACE-SP

Aceclofenac + Paracetamol + Serratiopeptidase for pain relief.

Form: Tablets
AMARCORT-6
Pain & Inflammation

AMARCORT-6

Deflazacort 6 mg - Corticosteroid for inflammatory conditions.

Form: Tablets
NORTUS-P
Neurology

NORTUS-P

Pregabalin + Nortriptyline for neuropathic pain management.

Form: Tablets
Amnerve-PG50
Neurology

Amnerve-PG50

Pregabalin SR 50 mg - Sustained release for neuropathic pain.

Form: Tablets
Amartam-Plus New
Urology

Amartam-Plus

Tamsulosin + Dutasteride for benign prostatic hyperplasia.

Form: Tablets
LEVOTAS-M New
Allergy/Respiratory

LEVOTAS-M

Levocetirizine + Montelukast for allergic rhinitis and asthma.

Form: Tablets
NUMVITUS 4G New
Nutrition

NUMVITUS 4G

Omega-3 + Multivitamin + Antioxidants for complete nutrition.

Form: Softgel Capsules
Our Process

From Research to Your Pharmacy

Our comprehensive development process ensures every medication meets the highest standards of quality, safety, and efficacy.

1

Research & Development

Cutting-edge research identifying new therapeutic targets and developing innovative formulations.

2

Clinical Trials

Rigorous testing phases ensuring safety and efficacy through comprehensive clinical studies.

3

Regulatory Approval

Meeting international regulatory standards and obtaining necessary approvals from health authorities.

4

Manufacturing & Distribution

State-of-the-art manufacturing facilities and global distribution networks ensuring accessibility.

Testimonials

Trusted by Healthcare Professionals

See what medical professionals and patients have to say about our pharmaceutical products and services.

"Mecon Life Science's cardiovascular medications have significantly improved patient outcomes in my practice. The quality and efficacy are unmatched."

Dr. Sarah Johnson

Cardiologist, Mayo Clinic

"The respiratory care products have been life-changing for my patients with chronic conditions. Reliable, effective, and consistently high quality."

Dr. Michael Chen

Pulmonologist, Johns Hopkins

"As a pharmacy director, I trust Mecon for their consistent quality, transparency, and commitment to patient safety. Excellent partner."

Lisa Martinez, PharmD

Pharmacy Director

Certifications

Globally Recognized Standards

Our commitment to quality is validated by international certifications and regulatory approvals.

FDA Approved

US Food and Drug Administration certified facilities

ISO 9001:2015

International quality management standards

GMP Certified

Good Manufacturing Practice compliance

WHO Listed

World Health Organization approved

Latest Updates

News & Insights

Stay updated with the latest developments, research breakthroughs, and industry insights from Mecon Life Science.

December 28, 2025

New Breakthrough in Cancer Treatment Research

Our research team announces promising results from Phase III trials of innovative oncology medication.

Read More
December 20, 2025

Expansion of Manufacturing Facilities

Mecon announces major investment in new state-of-the-art production facility to meet global demand.

Read More
December 15, 2025

Partnership with Global Health Initiative

Collaboration with WHO to provide affordable medications to underserved communities worldwide.

Read More

Ready to Learn More?

Our team of healthcare professionals is available to provide detailed product information and support.